investors

Investor Relations

Investor Relations

STERIS is a leading provider of infection prevention and procedural products and services, focused primarily on the critical markets of healthcare, pharmaceutical and research and medical devices. Our MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Recent Press Releases
07/27/21
STERIS to Host a Conference Call for Fiscal 2022 First Quarter Financial Results on August 10, 2021
06/02/21
STERIS Completes the Acquisition of Cantel Medical
05/18/21
STERIS Announces Financial Results for Fiscal 2021 Fourth Quarter and Full Year

Shareholder Tools